The peptide industry's explosive growth is built on hype far outpacing hard science, with most trendy compounds jumpingentering straightthe frommarket animal studies to human use without rigorous trials. Consumers, therefore, are injecting unregulated peptidepeptides productswith have no guarantee of safety, accurate dosing or long-term effects. PouringAs a result, pouring billions into scaling up peptide manufacturing before the evidence base catches up puts profits aheadbefore of patient protection.